New Data on GLP-1s, Diabetic Retinopathy, and CGMs—Highlights From the ADA’s Scientific Sessions
JAMA · 20.08.2024 · 332 (7) · 519
DOI: 10.1001/jama.2024.11510 ↗Kurz gefasst
Fachartikel in der Zeitschrift JAMA, erschienen am 20.08.2024. Verfasst von Jennifer Abbasi. Beteiligte Einrichtung: Director, Medical News & Perspectives, JAMA. Hauptthemen laut MEDLINE: Continuous Glucose Monitoring, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Diabetic Retinopathy. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
This Medical News article is an interview with Robert Gabbay, MD, PhD, the American Diabetes Association’s chief scientific and medical officer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Director, Medical News & Perspectives, JAMA.
Zitieren
APA
Abbasi, J. (2024). New Data on GLP-1s, Diabetic Retinopathy, and CGMs—Highlights From the ADA’s Scientific Sessions. JAMA, 332(7), 519. https://doi.org/10.1001/jama.2024.11510
Vancouver
Abbasi J. New Data on GLP-1s, Diabetic Retinopathy, and CGMs—Highlights From the ADA’s Scientific Sessions. JAMA. 2024;332(7):519. doi:10.1001/jama.2024.11510
BibTeX
@article{Abbasi2024,
author = {Abbasi, Jennifer},
title = {New Data on GLP-1s, Diabetic Retinopathy, and CGMs—Highlights From the ADA’s Scientific Sessions},
journal = {JAMA},
year = {2024},
volume = {332},
number = {7},
pages = {519},
doi = {10.1001/jama.2024.11510}
}
EUVIMED